Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Hong Kong has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Hong Kong have shifted towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more effective. This has led to an increased demand for natural and herbal remedies, which are often seen as gentler on the digestive system compared to traditional pharmaceutical options. Trends in the market indicate a growing interest in probiotics and digestive supplements. Probiotics have gained popularity due to their potential benefits for gut health and overall well-being. Consumers are increasingly seeking products that promote a healthy digestive system and improve digestion. Digestive supplements, such as enzymes and fiber supplements, are also in high demand as they are believed to aid digestion and alleviate common digestive issues. Local special circumstances, such as the high prevalence of certain digestive disorders in Hong Kong, have contributed to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. Hong Kong has a high incidence of digestive disorders, including irritable bowel syndrome (IBS) and acid reflux. This has created a significant market for products that provide relief from these conditions and improve digestive health. Underlying macroeconomic factors, such as the aging population and increasing healthcare expenditure, have also played a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Hong Kong. As the population ages, the prevalence of digestive disorders tends to increase, driving the demand for remedies and treatments. Additionally, the government's focus on healthcare and wellness has led to increased healthcare expenditure, which has further supported the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Hong Kong is developing due to changing customer preferences towards natural and herbal remedies, emerging trends in probiotics and digestive supplements, local special circumstances such as the high prevalence of digestive disorders, and underlying macroeconomic factors including the aging population and increasing healthcare expenditure. As these factors continue to shape the market, it is expected that the Digestive & Intestinal Remedies (Pharmacies) market in Hong Kong will continue to grow in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
